Preventing strokes: The assessment and management of people with transient ischaemic attack

New Zealand Medical Journal

Volumn 122, Issue 1293, 2009, Pages 50-60

  Gommans, John ^a,d   Barber, P Alan ^b   Fink, John ^c  

^a Hawke's Bay District Health Board   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^d HAWKE S BAY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DRUG THERAPY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; THIAZIDE DIURETIC AGENT; WARFARIN;

BEHAVIOR CHANGE; BEHAVIOR THERAPY; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; CAROTID ARTERY SURGERY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG COMBINATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPHASIA; EARLY DIAGNOSIS; EMERGENCY TREATMENT; ETIOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HEMIANOPIA; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LIFESTYLE; LIFESTYLE MODIFICATION; MALE; METHODOLOGY; MIGRAINE AURA; MONITORING; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MUSCLE WEAKNESS; NEW ZEALAND; NICOTINE REPLACEMENT THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVENTION; PRIMARY MEDICAL CARE; PROGNOSIS; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SMOKING CESSATION; SPEECH DISORDER; STROKE; SURVIVAL; SYMPTOM; THERAPY; TRANSIENT GLOBAL AMNESIA; TRANSIENT ISCHEMIC ATTACK; UNILATERAL BLINDNESS;

ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; COMPLICATIONS; DIAGNOSIS; DRUG THERAPY, COMBINATION; EMERGENCY TREATMENT; ETIOLOGY; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LIFE STYLE; MALE; METHODS; MONITORING, PHYSIOLOGIC; NEW ZEALAND; PREVENTION AND CONTROL; PROGNOSIS; RECURRENCE; RISK FACTORS; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL ANALYSIS; THERAPEUTIC USE; THERAPY;

EID: 67649965128     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Life after stroke: New Zealand guideline for management of stroke. Stroke Foundation of New Zealand: Wellington, 2003. http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm? &guidelineID=37
2. Diabetes and Cardiovascular Disease Quality Improvement Plan. Ministry of Health: Wellington, 2008. http://www.moh.govt.nz/moh.nsf/indexmh/ diabetes-cardio-quality-improvement-plan-feb08
3. National clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack. Royal College of Physicians: London, 2008. http://www.rcplondon.ac.uk/pubs/contents/ 9c4488ac-d8f1-43d8-b9da-b801441bcdfb.pdf
4. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-92.
5. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet. 2007;370(9596):1432-42.
6. Lavallee PC, Meseguer E, Abboud H, et al., A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): Feasibility and effects. Lancet Neurol. 2007;6(11):953-60.
7. New Zealand Guideline for the assessment and management of people with recent transient ischaemic attack. Wellington: Stroke Foundation of New Zealand, 2008. http://www.stroke.org.nz/pdfs/ TIA_GuidelineForweb.pdf
8. New Zealand Guideline for the Assessment and Management of Transient Ischaemic Attack (TIA): User Guide. Wellington: Stroke Foundation of New Zealand, 2008. http://www.stroke.org.nz/pdfs/TIA_UserGuideLR.pdf
9. Dennis MS, Bamford JM, Sandercock PA, et al. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke, 1989;20(3):333-9.
10. Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing. 2007;36(6):676-80.
11. Landi G. Clinical diagnosis of transient ischaemic attacks. Lancet. 1992;339(8790):402-5.
12. Wu CM, McLaughlin K, Lorenzetti DL, et al. Early risk of stroke after transient ischemic attack: A systematic review and meta-analysis. Arch Intern Med. 2007;167(22):2417-22.
13. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901-6.
14. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: Implications for public education and organisation of services. BMJ. 2004;328(7435):326.
15. Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29-36.
16. Josephson SA, Sidney S, Pham TN, et al. Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke. 2008;39(11):3096-8.
17. European Stroke Organisation Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457-507.
18. Clinical Guidelines for Acute Stroke Management. National Stroke Foundation (Australia): Melbourne, 2007. http://www.strokefoundation.com.au/ acute-clinical-guidelines-for-Acute-stroke-management
19. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: A quantitative modeling study. Stroke. 2007;38(6):1881-5.
20. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35(12):2879-83.
21. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: A systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-72.
22. National Stroke Strategy. Department of Health: London, 2007. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_081062
23. Sandercock PA, Counsell C, Gubitz GJ, et al. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;(3):CD000029.
24. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: A meta-analysis. Stroke. 2008;39(4):1358-63.
25. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;18;359(12):1238-51. Epub 2008 Aug 27.
26. Carotid Endarterectomy and Angioplasty - Karolinska Stroke Update Consensus Statement 15 November 2004. 2004. http://www.strokeupdate.org/ALLCURRENT/Consensus/Consensus_2004/ Cons_carotis_2004.htm
27. Medical aspects of fitness to drive: A guide to medical practitioners., Wellington: Land Transport Safety Authority, 2002. http://www.ltsa.govt.nz/licensing/docs/ltsa-medical-aspects.pdf